Pass That Dog Down
Eli Lilly and Company announced this month that they’re reducing the price of their most common insulin by 70% and capping patient out-of-pocket insulin costs at $35 or less a month. It might make cynical people wonder why. But in spite of how things feel these days, the overall arch ...
read more →
Pass That Dog Down Read More »